tiprankstipranks
Advertisement
Advertisement
Moderna falls -8.2%
PremiumThe FlyModerna falls -8.2%
10d ago
Moderna price target raised to $39 from $33 at Morgan Stanley
Premium
The Fly
Moderna price target raised to $39 from $33 at Morgan Stanley
12d ago
Moderna Strengthens Board with New Financial Director
Premium
Company Announcements
Moderna Strengthens Board with New Financial Director
12d ago
Early notable gainers among liquid option names on July 2nd
PremiumThe FlyEarly notable gainers among liquid option names on July 2nd
18d ago
Moderna’s Surprise Surge: Is the mRNA Giant Back?
Premium
Weekend Updates
Moderna’s Surprise Surge: Is the mRNA Giant Back?
23d ago
Why Moderna (MRNA) Stock Is Soaring Today – June 26, 2026
Premium
Market News
Why Moderna (MRNA) Stock Is Soaring Today – June 26, 2026
24d ago
Moderna Maintained at Hold as Analyst Weighs Leading mRNA Platform Against Early-Stage Pipeline Risks
PremiumRatingsModerna Maintained at Hold as Analyst Weighs Leading mRNA Platform Against Early-Stage Pipeline Risks
24d ago
Hold Rating Reiterated on Moderna as Analyst Keeps $49 Price Target Amid Long-Term Pipeline Potential and Near-Term Execution Risks
Premium
Ratings
Hold Rating Reiterated on Moderna as Analyst Keeps $49 Price Target Amid Long-Term Pipeline Potential and Near-Term Execution Risks
24d ago
Hold Rating Reaffirmed on Moderna as Analyst Highlights High-Risk/High-Reward Pipeline and Keeps Price Target Unchanged at $41
Premium
Ratings
Hold Rating Reaffirmed on Moderna as Analyst Highlights High-Risk/High-Reward Pipeline and Keeps Price Target Unchanged at $41
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100